Warby Parker (WRBY) Income from Continuing Operations (2020 - 2026)
Warby Parker (WRBY) reported Income from Continuing Operations of 3177000.0 for Q1 2026, down 8.5% on a YoY basis from 3472000.0 in Q1 2025, and up 153.37% quarter-over-quarter from 5953000.0 in Q4 2025.
Warby Parker (WRBY) Income from Continuing Operations (2020 - 2026) Analysis & Trends
Warby Parker has reported Income from Continuing Operations for 7 years, with the latest figure at 3177000.0 in Q1 2026.
- For the quarter ending Q1 2026, Income from Continuing Operations fell 8.5% year-over-year to 3177000.0; the trailing twelve-month figure through Mar 2026 stood at 1346000.0 (up 109.45% YoY), and the FY2025 full-year result was 1641000.0, up 108.05% from the prior year.
- Income from Continuing Operations for Q1 2026 stood at 3177000.0, up from 5953000.0 in the prior quarter.
- The five-year high for Income from Continuing Operations was 5874000.0 in Q3 2025, with the low at 34133000.0 in Q1 2022.
- Historically, Income from Continuing Operations has averaged 11127352.94 across 5 years, with a median of 6877000.0 in 2024.
- Annual changes were most pronounced in 2022 — Income from Continuing Operations plunged 1233.61% — and 2025, when it soared 244.25%.
- Warby Parker's Income from Continuing Operations stood at 20254000.0 in 2022, then increased by 5.96% to 19047000.0 in 2023, then jumped by 63.89% to 6877000.0 in 2024, then grew by 13.44% to 5953000.0 in 2025, then jumped by 153.37% to 3177000.0 in 2026.
- The last three Income from Continuing Operations figures came in at 3177000.0 (Q1 2026), 5953000.0 (Q4 2025), and 5874000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | 826.00 Mn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | -37.00 Mn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | 239.00 Mn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | 398.73 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | 135.40 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | 13.00 Mn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | -77.90 Mn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | 112.77 Mn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | -17.00 Mn |
| 10 | Warby Parker | 3.11 Bn | 2.82 Bn | 131.04 Mn | 3.18 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.18 Mn |
| Dec 31, 2025 | -5.95 Mn |
| Sep 30, 2025 | 5.87 Mn |
| Jun 30, 2025 | -1.75 Mn |
| Mar 31, 2025 | 3.47 Mn |
| Dec 31, 2024 | -6.88 Mn |
| Sep 30, 2024 | -4.07 Mn |
| Jun 30, 2024 | -6.76 Mn |
| Mar 31, 2024 | -2.68 Mn |
| Dec 31, 2023 | -19.05 Mn |
| Sep 30, 2023 | -17.41 Mn |
| Jun 30, 2023 | -15.93 Mn |
| Mar 31, 2023 | -10.81 Mn |
| Dec 31, 2022 | -20.25 Mn |
| Sep 30, 2022 | -23.84 Mn |
| Jun 30, 2022 | -32.17 Mn |
| Mar 31, 2022 | -34.13 Mn |
| Dec 31, 2021 | -45.90 Mn |
| Sep 30, 2021 | -91.07 Mn |
| Jun 30, 2021 | -10.31 Mn |